Filing Details
- Accession Number:
- 0001209191-19-060537
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-16 06:26:35
- Reporting Period:
- 2019-12-13
- Accepted Time:
- 2019-12-16 06:26:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1478069 | Contrafect Corp | CFRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1522151 | Cary Sucoff | 2155 South Ocean Blvd. Apt 2 Delray Beach FL 33483-6448 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2019-12-13 | 50,000 | $0.39 | 62,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The purchase reported in this Form 4 was made on the open market.
- The price reported is a weighted average price based on the shares purchased in multiple transactions. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price comprising the average set forth herein.